June 21, 2018

Leveraging ADAPT Biotargeting System would have significantly increased the probability of success

Data presented at the ESMO World Congress on Gastrointestinal Cancer 2018

Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study